IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BANDERA, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.850
NA - Nord America 8.252
AS - Asia 5.055
SA - Sud America 189
OC - Oceania 103
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 6
Totale 27.541
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.791
DE - Germania 3.812
GB - Regno Unito 3.433
IT - Italia 3.267
CN - Cina 2.132
SG - Singapore 1.205
SE - Svezia 952
RU - Federazione Russa 573
IE - Irlanda 457
IN - India 436
CA - Canada 414
FR - Francia 257
HK - Hong Kong 227
ID - Indonesia 221
TR - Turchia 198
FI - Finlandia 156
KR - Corea 141
VN - Vietnam 133
ES - Italia 129
UA - Ucraina 129
NL - Olanda 124
DK - Danimarca 115
JP - Giappone 103
AU - Australia 94
BR - Brasile 93
CH - Svizzera 85
BE - Belgio 80
TW - Taiwan 58
PL - Polonia 53
GR - Grecia 45
MX - Messico 42
CO - Colombia 41
IR - Iran 34
TH - Thailandia 32
RO - Romania 29
EU - Europa 28
MY - Malesia 27
AT - Austria 20
CZ - Repubblica Ceca 20
HU - Ungheria 19
NO - Norvegia 18
SA - Arabia Saudita 17
ZA - Sudafrica 17
CL - Cile 15
PT - Portogallo 14
SC - Seychelles 14
PE - Perù 13
IL - Israele 12
AE - Emirati Arabi Uniti 11
PH - Filippine 11
AR - Argentina 10
EG - Egitto 10
IQ - Iraq 10
PK - Pakistan 9
BG - Bulgaria 8
EC - Ecuador 8
KE - Kenya 8
LT - Lituania 8
NZ - Nuova Zelanda 8
RS - Serbia 8
BD - Bangladesh 7
BO - Bolivia 7
NG - Nigeria 7
HR - Croazia 6
LB - Libano 6
MK - Macedonia 6
UZ - Uzbekistan 6
DZ - Algeria 5
EE - Estonia 5
ET - Etiopia 4
GH - Ghana 4
LU - Lussemburgo 4
SI - Slovenia 4
UG - Uganda 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
BY - Bielorussia 3
MA - Marocco 3
SK - Slovacchia (Repubblica Slovacca) 3
GT - Guatemala 2
JO - Giordania 2
KW - Kuwait 2
MD - Moldavia 2
MO - Macao, regione amministrativa speciale della Cina 2
MT - Malta 2
NP - Nepal 2
TN - Tunisia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
FJ - Figi 1
GE - Georgia 1
GL - Groenlandia 1
GM - Gambi 1
Totale 27.553
Salva come PNG Salva come JPEG
Città #
Southend 3.131
Hanover 1.550
Frankfurt am Main 1.510
Chandler 1.010
Milan 937
Singapore 880
Fairfield 713
Ashburn 451
Dublin 444
Princeton 402
Wilmington 367
Seattle 358
Houston 311
Beijing 301
Woodbridge 299
Cambridge 294
Toronto 271
Ann Arbor 252
Boardman 214
Rome 183
Santa Clara 181
Jakarta 164
Shanghai 153
Redwood City 149
Dearborn 140
Bengaluru 138
Des Moines 137
Nanjing 135
Phoenix 107
Hong Kong 105
Istanbul 94
Dong Ket 92
Helsinki 92
Jacksonville 90
Berlin 89
New York 88
San Diego 74
Turin 73
Central District 59
Chicago 57
Guangzhou 54
Fuzhou 52
Pontedera 52
Shenyang 52
Brussels 51
Redmond 51
Changsha 50
Mountain View 50
Ottawa 49
Jinan 46
Seoul 46
Bühl 44
Grafing 44
Hangzhou 43
Wuhan 43
London 42
Serra 38
Andover 37
Boston 37
Genoa 37
Kent 37
Falls Church 35
Los Angeles 35
Nanchang 35
Quanzhou 35
Madrid 34
Fremont 33
Silver Spring 32
Paris 31
Bogotá 30
Nuremberg 30
Taipei 30
Zhengzhou 30
Zurich 30
Warsaw 28
Chengdu 26
Lappeenranta 26
Sakarya 26
Tokyo 26
Florence 25
Hebei 25
Palermo 25
Sydney 25
Padova 23
Scranton 23
Bologna 22
Athens 21
Naples 21
Upper Marlboro 21
Amsterdam 20
Jiaxing 20
São Paulo 20
Tianjin 20
Central 18
Montréal 18
Munich 18
Rho 18
Tappahannock 18
Brescia 17
Edinburgh 17
Totale 18.037
Salva come PNG Salva come JPEG
Nome #
Occupational HIV infection in a research laboratory with unknown mode of transmission : a case report 723
Mapping the human genetic architecture of COVID-19 582
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects Data from the ICONA Foundation Cohort 536
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 429
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients 409
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 398
Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trial 319
Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samples 304
CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals 285
Aumento del peso nelle persone che vivono con infezione da HIV: ritorno al benessere o effetto indesiderato della terapia antiretrovirale? = Weight gain in people living with HIV infection : return to health or adverse event of antiretroviral therapy? 273
Spoligotyping and mycobacterium tuberculosis 263
Hospital Acquired Infections in COVID-19 patients in sub intensive care unit 263
A second update on mapping the human genetic architecture of COVID-19 262
Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection 262
Fully immunocompetent CD8+ T lymphocytes are present in autologous haematopoietic stem cell transplantation recipients despite an ineffectual T-helper response 256
Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults : results of the "COPA" pilot randomized trial 255
Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response 251
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 244
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: an observational cohort study 243
Qualitative immune modulation by Interleukin-2 (IL-2) adjuvant therapy in immunological non responder HIV-infected patients 241
Evaluation of PCR in detection of Mycobacterium tuberculosis from formalin-fixed, paraffin-embedded tissues : comparison of four amplifiaction assays 239
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts : Data from the Icona Foundation Cohort 230
A PCR-colorimetric microwell plate hybridization assay for detection of Mycobacterium tuberculosis and M. avium from culture samples and Ziehl-Neelsen-positive smears 226
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study 218
Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances : results from a randomized controlled trial 213
PCR-hybridization assay for Mycobacterium avium complex: optimization of detection in peripheral blood from humans 212
Enhancing care for people living with HIV: current and future monitoring approaches 212
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 211
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 210
Adjuvant treatment of severe varicella pneumonia with intravenous varicella zoster virus-specific immunoglobulins 201
The NLRP3 Inflammasome Is Upregulated in HIV-Infected Antiretroviral Therapy-Treated Individuals with Defective Immune Recovery 199
Fatal respiratory infection due to ST308 VIM-1-producing Pseudomonas aeruginosa in a lung transplant recipient : case report and review of the literature 195
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 194
Response of an Italian reference institute to research challenges regarding a new pandemic: COVID-19 network 194
Interleukin-2 immunotherapy exerts a differential effect on CD4 and CD8 T cell dynamics 191
KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy 181
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen : worth the risk? 181
Comparison between Spoligotyping and IS6110 Restriction Fragment Polymorphism in Molecular Genotyping Analysis of Mycobacterium tuberculosis strains 181
Genetic insight into Covid-19 related liver injury 178
Analysis of the env V3 sequences obtained from patients with HIV type 1 infection treated with the immune modulant agent tucaresol 175
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 175
Genotyping analyses of tuberculosis transmission among immigrant residents in Italy 170
Discontinuation of initial antiretroviral therapy in clinical practice : Moving toward individualized therapy 169
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 169
A case of Costochondral abscess due to Corynebacterium minutissimum in an HIV-infected patient 167
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes 164
Nosocomial bacterial pneumonia in HIV-infected patients : risk factors for adverse outcome and implications for rational empiric antibiotic therapy 162
SARS-CoV-2-related atypical thyroiditis 162
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 162
Monitoring of transmission of tuberculosis between wild boars and cattle : genotypical analysis of strains by molecular epidemiology techniques 161
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α 158
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 157
Complement activation and endothelial perturbation parallel COVID-19 severity and activity 157
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting : data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 155
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy 155
A one health framework to estimate the cost of antimicrobial resistance 155
Towards rapid sepsis diagnosis and patients stratification : What's new from microbiology and omics science 154
Challenges in the Diagnosis and Management of Bacterial Lung Infections in Solid Organ Recipients: A Narrative Review 153
Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis 152
Neurocognitive impairment in HIV-infected naive patients with advanced disease: the role of virus and intrathecal immune activation 147
Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy 146
Red cell-bound antibodies and transfusion requirements in hospitalized patients with COVID-19 144
Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre cohort study 143
Rapid Detection and Quantification of Mycobacterium tuberculosis DNA in Paraffinized Samples by Droplet Digital PCR: A Preliminary Study 141
Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a question needing an answer 140
Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment 139
COVID-19: What happened to the healthcare workers of a research and teaching hospital in Milan, Italy? 139
Immunomodulants in HIV Infection 138
Autochthonous ST405 NDM-5 producing Escherichia coli causing fatal sepsis in Northern Italy 138
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population 138
Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease 137
Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment 137
Characteristics and clinical implications of carbapenemase-producing klebsiella pneumoniae colonization and infection, Italy 136
Inflammasome and Th17 activation in HIV+ immunological nonresponders 135
Characterization of immune failure by monocyte activation phenotypes in HIV-infected patients receiving antiretroviral therapy 135
Antiviral Treatments for Influenza 135
Darunavir-cobicistat-emtricitabine-tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era 130
Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID 129
HIV-associated neurocognitive impairment in the modern ART era : are we close to discovering reliable biomarkers in the setting of virological suppression? 129
Focal bone lesions in hiv-positive patient treated with tenofovir 128
Mucormycosis in CAPA, a possible fungal super-infection 128
Unusual T-cell repopulation after autologous stem cell transplantation for HIV-associated lymphoma 127
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 126
Inflammasome and Pyroptosis are Involved in The Lack of Immune Response During cART 125
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation : the IMMUNEF clinical trial 125
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 124
Thymic-and bone marrow-cellular reservoirs harbor phylogenetically distinct HIV strains and different resistance profiles 124
Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy 124
Use of anakinra in severe COVID-19: a case report 122
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 121
Gastrointestinal colonization with multidrug-resistant Gram-negative bacteria during extracorporeal membrane oxygenation: effect on the risk of subsequent infections and impact on patient outcome 120
SARS-CoV-2 anti-spike antibody titres after vaccination with BNT162b2 in naïve and previously infected individuals 118
Chromosomally integrated human herpesvirus 6 (ci-HHV-6) in autologous bone marrow transplant recipients: are we missing a reactivation or is it just mimicking? 117
Acute Human Immunodeficiency Virus (HIV) Infection Presenting With Bilateral Interstitial Pneumonia : Case Report and Discussion of Potential HIV-Induced Interstitial Pneumonia 116
Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence? 116
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection 115
Higher Levels of Peripheral Th17 T Cd4+ Cells are Associated With Immunological Non-Response in Hiv-Infected Patients Undereffective Art 114
Epidemiology of Mycobacterium avium infection in northern Italy 113
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 113
Congenital Hepatic Fibrosis as a Cause of Recurrent Cholangitis: A Case Report and Review of the Literature 112
Totale 19.180
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.623
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.623
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.301 0 0 0 0 230 444 316 276 424 326 143 142
2020/20213.380 204 266 224 266 318 392 208 280 299 334 279 310
2021/20225.756 236 218 301 280 306 313 705 1.331 719 424 302 621
2022/20234.558 549 460 331 475 483 750 175 301 464 101 325 144
2023/20245.150 180 274 259 316 970 495 510 357 238 350 579 622
2024/20253.325 500 928 444 923 530 0 0 0 0 0 0 0
Totale 28.889